A variant epidermal growth factor receptor protein in similarly expressed in benign hyperplastic and carcinomatous prostatic tissues in black and white men

West African Journal of Medicine

Volumn 26, Issue 1, 2007, Pages 42-47

  Olapade Olaopa, E Oluwabunmi ^a,b   Moscatello, D K ^c   MacKay, E H ^a   Ogunbiyi, J O ^b   Shittu, O B ^b   Terry, T R ^d   Okeke, L I ^b   Wong, A J ^d   Habib, F K ^a,b,e  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c NIGMS Human Mutant Cell Repository   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Black and white men; Cancer; EGFR; EGFRvIII; Growth factors; Immunohistochemistry; Prostate

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; STREPTAVIDIN;

ARTICLE; CANCER CHEMOTHERAPY; CAUCASIAN; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NEGRO; NIGERIA; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN VARIANT; SCORING SYSTEM; STATISTICAL ANALYSIS; TISSUE SECTION; UNITED KINGDOM;

AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NIGERIA; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; UNITED STATES;

EID: 34249079385     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer Statistics 2006. CA Cancer J Clin. 2006; 56: 106-30.
2. Ogunbiyi J, Shittu O. Increased incidence of prostate cancer in Nigerians. Journal of the National Medical Association. 1999; 91: 159-164.
3. Glover F, Coffey D, Douglas L, Cadogan M, Russell H, Tulloch T, Baker T, Wan R, Walsh P. The epidemiology of prostate cancer in Jamaica. The Journal of Urology. 1998; 159: 1984-1987.
4. Ghafoor A, Jemal A, Cokkinides V, Cardinez C, Murray T, Samuels A, Thun MJ. Cancer Statistics for African Americans. CA Cancer J Clin. 2002; 52: 326-41.
5. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007; 12: 20-37.
6. Powell I, Banerjee M, SakrW, Grignon D, Wood DP Jr, Novallo M., Pontes E. Should African-American men be tested for prostate carcinoma at an earlier age than white men? Cancer. 1999; 85: 472-477.
7. Makridakis N, Ross R, Pike M, Crocitto L, Kolonel L, Pearce C, Hendersen B, Reichardt J. Association of mis-sense association in SRD5A2 gene with prostate cancer in African-American and Hispanic Men in Los Angeles, USA. Lancet. 1999; 354: 975-978.
8. Olapade-Olaopa E, Muronda C, MacKay E, Danso A, Sandhu DP, Terry T, Habib FK. Androgen receptor protein expression in prostatic tissues in black and caucasian men. The Prostate. 2004; 59: 460-468.
9. Shuch B, Mikhail M, Satagopan J, Lee P, Yee H, Chang C, Cordon-Cardo C, Taneja S, Osman I. Racial disparity of epidermal growth factor receptor expression in prostatic disease. Journal of Clinical Oncology. 2004; 22: 4725-4729.
10. Underwood W, Wei J, Rubin M, Montie J, Resh J, Sanda M. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. Urologic Oncology. 2004; 22: 20-24.
11. Powell I, Banerjee M, Bianco F, Wood DP Jr, Dey J, Lai L, Heath M, Pontes E. The effect of race/ethnicity on prostate cancer treatment outcome is conditional: a review of Wayne State University data. Urology. 2004; 171: 1508-1512.
12. Gullick W. Type I growth factor receptors: current status and future work. Biochemical Society Symposia. 1998; 63: 193-198.
13. Prenzel N, Fischer O, Streit S, Hart S, Ullrich A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocrine Related Cancer 2001; 8: 11-31.
14. Gullick W. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. British Medical Bulletin. 1991; 47: 87-98.
15. Moscatello D, Holga-Madruga M, Godwin A, Ramirez G, Gunn G, Zoltick P, Biegel J, Hayes R, Wong, A. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumours. Cancer Research. 1995; 55: 5536-5539.
16. Wong A, Ruppert J, Bigner S, Grzeschik C, Humphrey P, Bigner D, Vogelstein, B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proceedings of the National Academy of Sciences, USA. 1992; 89: 2965-2969.
17. Olapade-Olaopa E, Horsburgh T, MacKay E, Sandhu D, Terry T, Moscatello D, Wong A., Habib F. Evidence for the differential expression of a variant EGF receptor in human prostate cancer. British Journal of Cancer. 2000; 82: 186-194.
18. Lorimer I. Mutant epidermal growth factor receptors as targets for cancer therapy. Current Cancer Drug Targets. 2002; 2: 91-102.
19. Humphrey P, Wong A, Vogelstein B, Zalutsky M, Fuller G, Archer G, Friedman H, Kwatra M, Bigner S, Bigner D. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptor in human glioblastoma. Proceedings of the National Academy of Sciences of USA. 1990; 87: 4207-4211.
20. Olapade-Olaopa EO, Moscatello DK, MacKay EH, Sandhu DP, Terry T R, Wong AJ, Habib FK. Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer. Afr J Med Med Sci. 2004; 33: 245-253.
21. Gleason D, Mellinger G, Group, T. V.A.C.U.R. Prediction of prognosis for prostate adenocarcinoma by combined histological grading and clinical staging. Journal of Urology. 1974; 111: 58-64.
22. Olapade-Olaopa EO, Ogunbiyi JO, MacKay EH, Muronda CA, Alonge TO, Danso AP, Moscatello DK, Sandhu DP, Shittu OB, Terry TR, Wong AJ, Habib FK. Further characterization of storage-related alterations in immunoreactivity of archival tissue sections and its implications for collaborative multicenter immunohistochemical studies. Appl Immunohistochem Mol Morphol. 2001; 9: 261-266.
23. Newby J, A'Hern R, Leek R, Smith I, Harris A, Dowsett M. Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand binding assay and clinical relevance in human breast cancer. British Journal of Cancer. 1995; 71: 1237-1242.
24. Olapade-Olaopa EO. The expression of a mutant epidermal growth factor receptor in prostatic tumours. BJU International. 2001; 87: 224-226.
25. Gaston K, Kim D, Singh S, Ford O, Mohler, J. Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. Journal of Urology. 2003; 170: 990-993.
26. Liu W, Innocenti F, Chen P, Das S, Cook EH Jr, Ratain, M. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clinical Cancer Research. 2003; 9: 1009-1012.
27. Beers R, Chowdhury P, Bigner D, Pastan, I. Immunotoxins with increased activity against epidermal growth factor receptor vIII-expressing cells produced by antibody phage display. Clinical Cancer Research. 2000; 6: 2835-2843.
28. Luwor R, Johns T, Murone C, Huang H, Cavenee W, Ritter G, Old L, Burgess A, Scott A. Antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. Cancer Research. 2001; 61: 5355-5361.
29. Moscatello D, Ramirez G, Wong A. A naturally occuring mutant human epidermal growth factor as a target for peptide vaccine immunotherapy of tumours. Cancer Research. 1997; 57: 1419-1424.
30. Lorimer I, Lavictoire S. Targetting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain to the envelope glycoprotein receptor binding lobe. Journal of Immunological Methods. 2000; 237: 147-157.
31. Alteris-Therapeutics-Inc ALT-110. http://www.alteristhera.com/ clinical.htm, (Accessed on 5th October, 2005).